🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the substance there before directing customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

Based on TikTok, the service has removed violative material and banned related keywords and search suggestions. The organization stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with images of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one group, a seller posted contact information, where the majority of transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Item Information and Costs

Inside these groups, messages show black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already encountered patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly significant health risks”.